Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Pardi

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Nature Nanotechnology|June 23, 2025
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modificationsMáté Vadovics, Wenchen Zhao, Emily F Daley, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Computationally designed mRNA-launched protein nanoparticle vaccinesGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2025
Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivoVladimir V Shuvaev, Ying K Tam, Benjamin W Lee, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
Science Translational Medicine|October 15, 2025
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in miceGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.
Immunity|August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in MiceDorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Science Translational Medicine|June 11, 2025
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Nature Nanotechnology|June 23, 2025
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modificationsMáté Vadovics, Wenchen Zhao, Emily F Daley, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Computationally designed mRNA-launched protein nanoparticle vaccinesGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2025
Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivoVladimir V Shuvaev, Ying K Tam, Benjamin W Lee, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
Science Translational Medicine|October 15, 2025
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in miceGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.
Immunity|August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in MiceDorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Science Translational Medicine|June 11, 2025
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Pageof 15